SCHEMBL7143542

SCHEMBL7143542

CC(=NO)c1cccc(S(=O)(=O)NC(=O)Nc2c(C(C)C)cccc2C(C)C)c1

nearest known ligand 0.67

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
NLRP3 Q96P20 7/20 0.67

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7143539 1.00 NLRP3 (0.67) NLRP3
SCHEMBL7611971 0.95 NLRP3 (0.61) NLRP3
SCHEMBL7611975 0.95 NLRP3 (0.61) NLRP3
SCHEMBL7137733 0.91 NLRP3 (0.67) NLRP3
SCHEMBL7137728 0.91 NLRP3 (0.67) NLRP3
SCHEMBL7146088 0.88 NLRP3 (0.73) NLRP3
SCHEMBL7145863 0.88 NLRP3 (0.64) NLRP3
SCHEMBL7145857 0.88 NLRP3 (0.64) NLRP3
SCHEMBL7142167 0.85 NLRP3 (0.60) NLRP3
SCHEMBL7142164 0.85 NLRP3 (0.60) NLRP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0964849-B1 SULFONYL UREA DERIVATIVES AND THEIR USE IN THE CONTROL OF INTERLEUKIN-1 ACTIVITY PFIZER (US) 2003-06-04 EP disclosed
EP-1270554-A1 Sulfonyl urea derivatives and their use in the control of interleukin-1 activity PFIZER INC. (US) 2003-01-02 EP disclosed
EP-1270565-A1 4-Substituted furan-2-sulfonamide and its use in the preparation of sulfonyl urea derivatives PFIZER INC. (US) 2003-01-02 EP disclosed
US-6433009-B1 TREATMENT OF AUTOIMMUNE, CARDIOVASCULAR, NERVOUS SYSTEM, GASTROINTESTINAL, RESPIRATORY SYSTEM, AND VIRAL DISORDERS; ANTIDIABETIC, ANTIARTHRITIC, ANTIINFLAMMATORY AND ANTIDEPRESSANT AGENTS PFIZER INC 2002-08-13 US disclosed
US-6166064-A Sulfonyl urea derivatives and their use in the control of interleukin-1 activity PFIZER INC (US) 2000-12-26 US disclosed